High throughput CRISPR perturbation screens identify epigenetic regulators impacting primordial germ cell development [RNA-seq]
RNA-seq (gene expression) · mouse · 15 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 15 samples: 5 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Scalable primordial germ cell-like-cell platform for functional genomics identifies epigenetic fertility modifiersbioRxiv : the preprint server for biology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE259290_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1080592 and SRA study SRP491818. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 15 samples.
How we read this: 5 replicated groups read from 15 sample titles; they account for 15 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8113380 Embryoid bodies, no treatment, Stella pos, day6, rep1 Embryoid bodies, no tre…
- GSM8113381 Embryoid bodies, no treatment, Stella pos, day6, rep2 Embryoid bodies, no tre…
- GSM8113382 Embryoid bodies, no treatment, Stella pos, day6, rep3 Embryoid bodies, no tre…
- GSM8113383 Embryoid bodies, SB, Stella pos, day6, rep1 Embryoid bodies, SB, St…
- GSM8113384 Embryoid bodies, SB, Stella pos, day6, rep2 Embryoid bodies, SB, St…
- GSM8113385 Embryoid bodies, SB, Stella pos, day6, rep3 Embryoid bodies, SB, St…
- GSM8113386 Embryoid bodies, SB, Stella neg, day6, rep1 Embryoid bodies, SB, St…
- GSM8113387 Embryoid bodies, SB, Stella neg, day6, rep2 Embryoid bodies, SB, St…
- GSM8113388 Embryoid bodies, SB, Stella neg, day6, rep3 Embryoid bodies, SB, St…
- GSM8113389 Embryoid bodies, VPA, Stella pos, day6, rep1 Embryoid bodies, VPA, S…
- GSM8113390 Embryoid bodies, VPA, Stella pos, day6, rep2 Embryoid bodies, VPA, S…
- GSM8113391 Embryoid bodies, VPA, Stella pos, day6, rep3 Embryoid bodies, VPA, S…
- GSM8113392 Embryoid bodies, VPA, Stella neg, day6, rep1 Embryoid bodies, VPA, S…
- GSM8113393 Embryoid bodies, VPA, Stella neg, day6, rep2 Embryoid bodies, VPA, S…
- GSM8113394 Embryoid bodies, VPA, Stella neg, day6, rep3 Embryoid bodies, VPA, S…
- GSE334845 Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors [RNA-Seq] 86 samples shares crispr, regulators, screens, rna-seq
- GSE270509 In vivo CRISPR screen reveals interplay of epigenetic regulators underlies kinetics of hepatobiliary reprogramming [RNA-Seq] 27 samples shares crispr, epigenetic, regulators, rna-seq
- GSE334890 Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors 48 samples shares crispr, regulators, screens
- GSE338899 In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion 12 samples shares crispr, screens
- GSE302791 Targeted CRISPR-Cas9 screening identifies core transcription factors controlling murine haemato-endothelial fate commitment [RNA-seq] 12 samples shares crispr, rna-seq
- GSE225237 Reevaluation by CRISPR-Cas9 approach reveals multiple lincRNAs dispensable for pluripotency maintenance and SNORA73 essential for pluripotency exit (RNA-Seq) 12 samples shares crispr, rna-seq
- GSE249759 In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer 12 samples shares crispr, screens
- GSE306058 scCRISPR screens of CD8⁺ T cells in young vs. aged tumors and tdLNs 11 samples shares crispr, screens
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.